Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: insights from the CANVAS Program and CREDENCE trial
20 May 2023 (08:00 - 20:00)
Organised by: 
About the speaker
McGill University Health Centre, Montreal (Canada)
5 More presentations in this session
Doctor M. Rocha (Porto, PT)
Doctor I. Fialho (Lisbon, PT)
Doctor X. Wang (Indianapolis, US)
Access the full session
The Event
Heart Failure 2023
20 May - 23 May 2023
